Office of Research & Development |
|
Project Number: | 1-I01BX005734-01A2 |
| Title: | Monoclonal antibody inhibition of thrombin cleavage of osteopontin as a novel therapeutic to enhance host antitumor immunity and reduce cardiac fibrosis |
| Principal Investigator: | Lawrence L Leung |
| Location: | Palo Alto, CA |
| Congressional District Code: | 16 |
| Portfolio: | Precision Oncology Research |
| Project Period: | April 2024 - March 2028 |
| Total Award Amount: | $550,000 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |